Evidence map›Paper›PMID 25996839›Full record

ArticlePloS one2015

Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.

Katarzyna Danis-Wlodarczyk, Tomasz Olszak, Michal Arabski, Slawomir Wasik, Grazyna Majkowska-Skrobek, Daria Augustyniak, Grzegorz Gula, Yves Briers, Ho Bin Jang, Dieter Vandenheuvel and 3 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Antibiotics (Basel, Switzerland) · 2026
    Article
  3. Understanding phage Receptor-binding protein interaction with host surface receptor: the key for phage-Mediated detection and elimination of Pseudomonas aeruginosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. CombattingAntibiotics (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Chitosan-based matrix as a carrier for bacteriophages.Applied microbiology and biotechnology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Interlaboratory comparison ofJournal of clinical microbiology · 2023
    Article
  18. Phage-antibiotic combinations against multidrug-resistantAntimicrobial agents and chemotherapy · 2023
    Article
  19. Article
  20. Biology · 2023
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Katarzyna Danis-WlodarczykDepartment of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Wroclaw, Poland; Division of Gene Technology, Catholic University of Leuven, Leuven, Belgium.
Tomasz OlszakDepartment of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Wroclaw, Poland.
Michal ArabskiDepartment of Microbiology, Institute of Biology, The Jan Kochanowski University in Kielce, Kielce, Poland.
Slawomir WasikDepartment of Molecular Physics, Institute of Physics, The Jan Kochanowski University in Kielce, Kielce, Poland.
Grazyna Majkowska-SkrobekDepartment of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Wroclaw, Poland.
Daria AugustyniakDepartment of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Wroclaw, Poland.
Grzegorz GulaDepartment of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Wroclaw, Poland.
Yves BriersDivision of Gene Technology, Catholic University of Leuven, Leuven, Belgium.
Ho Bin JangDivision of Gene Technology, Catholic University of Leuven, Leuven, Belgium.
Dieter VandenheuvelDivision of Gene Technology, Catholic University of Leuven, Leuven, Belgium.
Katarzyna Anna DudaDivision of Structural Biochemistry, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany.
Rob LavigneDivision of Gene Technology, Catholic University of Leuven, Leuven, Belgium.
Zuzanna Drulis-KawaDepartment of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We here describe two novel lytic phages, KT28 and KTN6, infecting Pseudomonas aeruginosa, isolated from a sewage sample from an irrigated field near Wroclaw, in Poland. Both viruses show characteristic features of Pbunalikevirus genus within the Myoviridae family with respect to shape and size of head/tail, as well as LPS host receptor recognition. Genome analysis confirmed the similarity to other PB1-related phages, ranging between 48 and 96%. Pseudomonas phage KT28 has a genome size of 66,381 bp and KTN6 of 65,994 bp. The latent period, burst size, stability and host range was determined for both viruses under standard laboratory conditions. Biofilm eradication efficacy was tested on peg-lid plate assay and PET membrane surface. Significant reduction of colony forming units was observed (70-90%) in 24 h to 72 h old Pseudomonas aeruginosa PAO1 biofilm cultures for both phages. Furthermore, a pyocyanin and pyoverdin reduction tests reveal that tested phages lowers the amount of both secreted dyes in 48-72 h old biofilms. Diffusion and goniometry experiments revealed the increase of diffusion rate through the biofilm matrix after phage application. These characteristics indicate these phages could be used to prevent Pseudomonas aeruginosa infections and biofilm formation. It was also shown, that PB1-related phage treatment of biofilm caused the emergence of stable phage-resistant mutants growing as small colony variants.

Indexed as

BiofilmsBacteriophagesGenome, ViralGenomicsPhylogenyPseudomonas aeruginosaReceptors, VirusReceptors, Virus

Identifiers

PMID25996839
PMCPMC4440721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.